Concepedia

Isabella Montagna

IM

Statistics

Publications

5

Citations

1.5K

H-Index

5

Active since

2016

Affiliations

University of Parma(Current)

Chiesi (Italy)

University of Ferrara

Chiesi (France)

Manchester University NHS Foundation Trust

Isabella Montagna is an author at University of Parma specializing in chronic obstructive pulmonary disease, pulmonology, and bronchodilator therapy.

Publications per year

2016–2022

5

Publications

5

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

Alberto Papi, Jørgen Vestbo, Leonardo M. Fabbri et al. · The Lancet · 2018 · 631 citations · Full text

, , +14

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 442 citations · Full text

, , +17

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, Alberto Papi, Massimo Corradi et al. · The Lancet · 2016 · 424 citations · Full text

, , +17

Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials

Eva Topole, Sonia Biondaro, Isabella Montagna et al. · ERJ Open Research · 2022 · 26 citations · Full text

, , +17

11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation

Chloe Fenton, Ana Crastin, Claire Martin et al. · International Journal of Molecular Sciences · 2022 · 14 citations · Full text

, , +16

1–5 of 5